Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity

Vaccine

Volumn 32, Issue 43, 2014, Pages 5546-5548

  Ambrose, Christopher S ^a   Wu, Xionghua ^b   Caspard, Herve ^a   Belshe, Robert B ^c  

^a ASTRAZENECA   (United Kingdom)

^b MEDIMMUNE   (United States)

^c S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

Disease severity; Influenza; Live attenuated influenza vaccine

Indexed keywords

INFLUENZA VACCINE; PLACEBO; LIVE VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; CHILD; DISEASE SEVERITY; DRUG EFFICACY; FEVER; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFORMATION RETRIEVAL; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); INFLUENZA, HUMAN; META ANALYSIS; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

CHILD; CHILD, PRESCHOOL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; VACCINES, ATTENUATED;

EID: 84908459107     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.097     Document Type: Article

References (18)

1. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344:889-896.
2. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 2004, 190:1369-1373.
3. Longini I.M., Halloran M.E. Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 2005, 161:303-306.
4. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002, 185:147-152.
5. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G., Riggs M., Griffith M., et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005, 23:1540-1548.
6. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1-62.
7. Baguelin M., Flasche S., Camacho A., Demiris N., Miller E., Edmunds W.J. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 2013, 10:e1001527.
8. Jain V.K., Rivera L., Zaman K., Espos R.A., Sirivichayakul C., Quiambao B.P., et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013, 369:2481-2491.
9. Influenza Vaccine Live, Intranasal. Full Prescribing Information 2012, MedImmune, Gaithersburg, MD.
10. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356:685-696.
11. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998, 338:1405-1412.
12. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000, 136:168-175.
13. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
14. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006, 25:860-869.
15. Ashkenazi S., Vertruyen A., Aristegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006, 25:870-879.
16. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011, 204:845-853.
17. Forrest B.D., Pride M.W., Dunning A.J., Capeding M.R., Chotpitayasunondh T., Tam J.S., et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008, 15:1042-1053.
18. Ambrose C.S., Wu X., Jones T., Mallory R.M. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 2012, 30:6794-6801.